1. Home
  2. DRD vs BCRX Comparison

DRD vs BCRX Comparison

Compare DRD & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DRDGOLD Limited

DRD

DRDGOLD Limited

HOLD

Current Price

$25.92

Market Cap

2.5B

ML Signal

HOLD

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

HOLD

Current Price

$8.26

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRD
BCRX
Founded
1895
1986
Country
South Africa
United States
Employees
3410
N/A
Industry
Precious Metals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.3B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
DRD
BCRX
Price
$25.92
$8.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
11
Target Price
$32.63
$20.82
AVG Volume (30 Days)
234.3K
4.2M
Earning Date
08-19-2026
05-06-2026
Dividend Yield
2.24%
N/A
EPS Growth
N/A
381.40
EPS
N/A
N/A
Revenue
N/A
$25,186,000.00
Revenue This Year
$39.23
N/A
Revenue Next Year
$30.12
$12.55
P/E Ratio
$15.32
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.08
$6.00
52 Week High
$39.37
$11.31

Technical Indicators

Market Signals
Indicator
DRD
BCRX
Relative Strength Index (RSI) 38.87 37.55
Support Level $23.26 $7.94
Resistance Level $30.99 $8.68
Average True Range (ATR) 1.06 0.46
MACD -0.22 -0.08
Stochastic Oscillator 5.78 23.34

Price Performance

Historical Comparison
DRD
BCRX

About DRD DRDGOLD Limited

DRDGold Ltd is a South African gold mining company engaged in surface gold tailings retreatment including exploration, extraction, processing, and smelting. Its reportable operating segments are; Ergo, FWGR, and Corporate office and other reconciling items. The Ergo is a surface gold retreatment operation that treats old slime dams and sand dumps to the south of Johannesburg's central business district as well as the East and Central Rand goldfields, and the FWGR which is a surface gold retreatment operation and treats old slime dams in the West Rand goldfields. The Ergo segment derives a vast majority of the company's revenue.

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: